BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

783 related articles for article (PubMed ID: 25920022)

  • 21. Characterization of the observe zone of the ESC 2015 high-sensitivity cardiac troponin 0h/1h-algorithm for the early diagnosis of acute myocardial infarction.
    Nestelberger T; Wildi K; Boeddinghaus J; Twerenbold R; Reichlin T; Giménez MR; Puelacher C; Jaeger C; Grimm K; Sabti Z; Hillinger P; Kozhuharov N; du Fay de Lavallaz J; Pinck F; Lopez B; Salgado E; Miró Ò; Bingisser R; Lohrmann J; Osswald S; Mueller C
    Int J Cardiol; 2016 Mar; 207():238-45. PubMed ID: 26808985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined determination of highly sensitive troponin T and copeptin for early exclusion of acute myocardial infarction: first experience in an emergency department of a general hospital.
    Lotze U; Lemm H; Heyer A; Müller K
    Vasc Health Risk Manag; 2011; 7():509-15. PubMed ID: 21915168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can copeptin and troponin T ratio predict final infarct size and myocardial salvage index in patients with ST-elevation myocardial infarction: A sub-study of the DANAMI-3 trial.
    Árnadóttir Á; Schoos M; Lønborg J; Ahtarovski K; Kelbæk H; Helqvist S; Høfsten D; Clemmensen P; Engstrøm T; Nepper-Christensen L; Vejlstrup N; Køber L; Iversen K
    Clin Biochem; 2018 Sep; 59():37-42. PubMed ID: 29932892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A multicentre, randomized, controlled open-label trial to compare an Accelerated Rule-Out protocol using combined prehospital copeptin and in-hospital high sensitive troponin with standard rule-out in patients suspected of acute Myocardial Infarction - the AROMI trial.
    Pedersen CK; Stengaard C; Søndergaard H; Dodt KK; Hjort J; Bøtker MT; Terkelsen CJ
    Trials; 2018 Dec; 19(1):683. PubMed ID: 30541594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Instant rule-out of suspected non-ST-segment elevation myocardial infarction using high-sensitivity cardiac troponin T with Copeptin versus a single low high-sensitivity cardiac troponin T: findings from a large pooled individual data analysis on 10,329 patients.
    Giannitsis E; Huber K; Hamm CW; Möckel M
    Clin Res Cardiol; 2021 Feb; 110(2):194-199. PubMed ID: 32671467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid rule out of acute myocardial infarction using undetectable levels of high-sensitivity cardiac troponin.
    Rubini Giménez M; Hoeller R; Reichlin T; Zellweger C; Twerenbold R; Reiter M; Moehring B; Wildi K; Mosimann T; Mueller M; Meller B; Hochgruber T; Ziller R; Sou SM; Murray K; Sakarikos K; Ernst S; Gea J; Campodarve I; Vilaplana C; Haaf P; Steuer S; Minners J; Osswald S; Mueller C
    Int J Cardiol; 2013 Oct; 168(4):3896-901. PubMed ID: 23876467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Addition of copeptin improves diagnostic performance of point-of-care testing (POCT) for cardiac troponin T in early rule-out of myocardial infarction - A pilot study.
    Vafaie M; Biener M; Mueller M; Abu Sharar H; Hartmann O; Hertel S; Katus HA; Giannitsis E
    Int J Cardiol; 2015 Nov; 198():26-30. PubMed ID: 26149334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Copeptin helps in the early detection of patients with acute myocardial infarction: primary results of the CHOPIN trial (Copeptin Helps in the early detection Of Patients with acute myocardial INfarction).
    Maisel A; Mueller C; Neath SX; Christenson RH; Morgenthaler NG; McCord J; Nowak RM; Vilke G; Daniels LB; Hollander JE; Apple FS; Cannon C; Nagurney JT; Schreiber D; deFilippi C; Hogan C; Diercks DB; Stein JC; Headden G; Limkakeng AT; Anand I; Wu AHB; Papassotiriou J; Hartmann O; Ebmeyer S; Clopton P; Jaffe AS; Peacock WF
    J Am Coll Cardiol; 2013 Jul; 62(2):150-160. PubMed ID: 23643595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Copeptin does not add diagnostic information to high-sensitivity troponin T in low- to intermediate-risk patients with acute chest pain: results from the rule out myocardial infarction by computed tomography (ROMICAT) study.
    Karakas M; Januzzi JL; Meyer J; Lee H; Schlett CL; Truong QA; Rottbauer W; Bamberg F; Dasdemir S; Hoffmann U; Koenig W
    Clin Chem; 2011 Aug; 57(8):1137-45. PubMed ID: 21673277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serial sampling of copeptin levels improves diagnosis and risk stratification in patients presenting with chest pain: results from the CHOPIN trial.
    Marston NA; Shah KS; Mueller C; Neath SX; Christenson RH; McCord J; Nowak RM; Daniels LB; Hollander JE; Apple F; Nagurney J; Schreiber D; deFilippi C; Diercks D; Limkakeng A; Anand IS; Wu AH; Jaffe AS; Peacock WF; Maisel AS
    Emerg Med J; 2016 Jan; 33(1):23-9. PubMed ID: 26105583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utility of 14 novel biomarkers in patients with acute chest pain and undetectable levels of conventional cardiac troponin.
    Meune C; Balmelli C; Twerenbold R; Reiter M; Reichlin T; Ziller R; Drexler B; Stelzig C; Freese M; Wolf C; Haaf P; Osswald S; Mueller C
    Int J Cardiol; 2013 Aug; 167(4):1164-9. PubMed ID: 22507551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis of Acute Myocardial Infarction in Hemodialysis Patients With High-Sensitivity Cardiac Troponin T Assay.
    Huang HL; Zhu S; Wang WQ; Nie X; Shi YY; He Y; Song HL; Miao Q; Fu P; Wang LL; Li GX
    Arch Pathol Lab Med; 2016 Jan; 140(1):75-80. PubMed ID: 26717058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biomarkers-in-Cardiology 8 RE-VISITED-Consistent Safety of Early Discharge with a Dual Marker Strategy Combining a Normal hs-cTnT with a Normal Copeptin in Low-to-Intermediate Risk Patients with Suspected Acute Coronary Syndrome-A Secondary Analysis of the Randomized Biomarkers-in-Cardiology 8 Trial.
    Giannitsis E; Garfias-Veitl T; Slagman A; Searle J; Müller C; Blankenberg S; von Haehling S; Katus HA; Hamm CW; Huber K; Vollert JO; Möckel M
    Cells; 2022 Jan; 11(2):. PubMed ID: 35053326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-sensitivity cardiac troponin in the distinction of acute myocardial infarction from acute cardiac noncoronary artery disease.
    Haaf P; Drexler B; Reichlin T; Twerenbold R; Reiter M; Meissner J; Schaub N; Stelzig C; Freese M; Heinzelmann A; Meune C; Balmelli C; Freidank H; Winkler K; Denhaerynck K; Hochholzer W; Osswald S; Mueller C
    Circulation; 2012 Jul; 126(1):31-40. PubMed ID: 22623715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Small changes in troponin T levels are common in patients with non-ST-segment elevation myocardial infarction and are linked to higher mortality.
    Bjurman C; Larsson M; Johanson P; Petzold M; Lindahl B; Fu MLX; Hammarsten O
    J Am Coll Cardiol; 2013 Oct; 62(14):1231-1238. PubMed ID: 23933541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic value of copeptin in acute myocardial infarction.
    Ay MO; Erenler AK; Dogan T; Yetim M
    Eur Rev Med Pharmacol Sci; 2017 Apr; 21(7):1576-1582. PubMed ID: 28429348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid exclusion of acute myocardial infarction in patients with undetectable troponin using a high-sensitivity assay.
    Body R; Carley S; McDowell G; Jaffe AS; France M; Cruickshank K; Wibberley C; Nuttall M; Mackway-Jones K
    J Am Coll Cardiol; 2011 Sep; 58(13):1332-9. PubMed ID: 21920261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-sensitivity cardiac troponin T for earlier diagnosis of acute myocardial infarction in patients with initially negative troponin T test--comparison between cardiac markers.
    Kitamura M; Hata N; Takayama T; Hirayama A; Ogawa M; Yamashina A; Mera H; Yoshino H; Nakamura F; Seino Y
    J Cardiol; 2013 Dec; 62(6):336-42. PubMed ID: 23867331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incremental value of high-sensitivity cardiac troponin T for risk prediction in patients with suspected acute myocardial infarction.
    Hochholzer W; Reichlin T; Twerenbold R; Stelzig C; Hochholzer K; Meissner J; Haaf P; Schaub N; Steuer S; Bassetti S; Reiter M; Roost K; Freidank H; Winkler K; Mueller C
    Clin Chem; 2011 Sep; 57(9):1318-26. PubMed ID: 21771945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomised Assessment of Treatment using Panel Assay of Cardiac markers--Contemporary Biomarker Evaluation (RATPAC CBE).
    Collinson PO; Gaze DC; Thokala P; Goodacre S
    Health Technol Assess; 2013; 17(15):v-vi, 1-122. PubMed ID: 23597479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.